Shyld AI

If the buyer requires extensive, independently verified peer reviews and mature procurement artifacts

• Established alternatives may provide a larger public evidence base and more referenceable deployments.

If the organization’s infection prevention strategy is standardized around mobile UV robots and workflow change is not feasible

• Adopting a room-mounted automated approach may require process redesign and stakeholder alignment.

If the security program mandates publicly documented certifications (SOC 2 Type II / ISO 27001)

• Publicly documented security attestations were not found during this review; buyers that require such documentation prior to procurement may prefer a vendor that publishes those artifacts.

If the primary objective is only room disinfection without a need for workflow analytics

• A simpler UV solution or managed disinfection service may be lower cost and easier to justify.

If international deployments and a broad global service organization are required

• Early-stage vendors may have limited geographic support capacity.

Current limitations documented in public sources

• There is no explicit public "known issues" page located on shyld.ai during this review.

Features on the roadmap

• Not publicly documented; press suggests potential expansion beyond disinfection into broader hospital operations intelligence.

Scale limitations

• Not publicly documented; scaling an edge fleet raises questions about centralized management, patching, and observability that buyers should discuss with the vendor.

Security or compliance gaps

• Public documentation of security certifications and enterprise security features was not found; buyers should request security packages, penetration test results, and compliance documentation during procurement.

Technical and integration constraints

• Not publicly documented; buyers should ask about:
  • API availability and integration patterns.
  • SSO/SAML and directory provisioning (SCIM).
  • Audit log export capabilities.
  • Integration into perioperative scheduling systems and facilities dashboards.

• Reported clinical impact: press and a cited study report reductions in surface bioburden associated with the system; the study indicates vendor funding/support and should be reviewed for study design and generalizability.
• Differentiation as described by the vendor: combination of room sensing, automated UV‑C cycle initiation, and operational timeline/logging in a room-mounted device.
• Unique features competitors may not provide in the same way: continuous room-activity-derived operational timelines and automated initiation of disinfection cycles tied to sensed conditions.

• Larger public review footprint, a longer operating history, and deeper published evidence libraries among some established UV vendors.

• Study design (control conditions, cleaning protocols, measurement techniques, and endpoints).
• Generalizability across room types (endoscopy units versus operating rooms versus inpatient rooms).
• Operational constraints such as cycle duration, vacancy-detection accuracy, and safety interlocks.

• Translate room activity into operational timelines and workflow metrics (notably operating room case progression and turnover).
• Initiate and record UV‑C disinfection cycles and maintain logs for infection prevention and compliance reporting.

• Perioperative leadership (OR directors, perioperative operations, anesthesia/OR management).
• Infection prevention and environmental services (EVS) leadership.
• Hospital operations, quality, and compliance teams.

• A combined OR workflow intelligence and automated disinfection offering, distinct from vendors that supply only mobile UV robots.
• A room-mounted approach intended to operate without staff-driven repositioning of devices.